NCT03494712View on ClinicalTrials.gov

Safety of Single Intravenous Administration of S95010 in Human Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 21, 2018

Primary Completion Date

April 10, 2019

Study Completion Date

April 10, 2019

Conditions
Cardiovascular Diseases
Interventions
DRUG

S 95010

Single administration of S 95010 in healthy volunteers

OTHER

Placebo

Single administration of placebo in healthy volunteers

Trial Locations (1)

B-2060

SGS Clinical Pharmacology Unit - Stuivenberg Hospital, Antwerp

All Listed Sponsors
collaborator

ADIR, a Servier Group company

INDUSTRY

lead

Institut de Recherches Internationales Servier

OTHER

NCT03494712 - Safety of Single Intravenous Administration of S95010 in Human Healthy Volunteers | Biotech Hunter | Biotech Hunter